GPs prescribing Mounjaro

As you will be aware, NHS England is making tirzepatide (Mounjaro) available in a phased approached over the next few years.

NICE guidelines say that in order to gain access to tirzepatide (Mounjaro) on the NHS, patients must also be referred on to a diet and exercise support programme.

Although it has been announced that it will become available in primary care settings from Monday, 23 June (for a specific patient cohort) arrangements are being made by Kent and Medway ICB to mobilise a provider of the necessary Behavioural Support for Obesity Prescribing (BSOP) that is specified in the NICE guidelines.

Until this service is in place in Kent and Medway, it is not possible to prescribe tirzepatide (Mounjaro) in primary care. This means your GP Practice is unable to prescribe these medicines solely for weight loss at this time.

Please also note there is no provider of tirzepatide (Mounjaro) available under right to choose.

Once the service becomes available to be prescribed, the first cohort of patients must have a BMI (Body Mass Index) of 40 plus and four or more of the following diagnosed health conditions:

• type 2 diabetes
• high blood pressure
• heart disease
• obstructive sleep apnoea
• abnormal blood fats (dyslipidaemia).

NHS England have created some frequently asked questions regarding this service, please visit here.

Published: Jun 27, 2025